| Characteristic . | No. of Gram-Negative Pathogensa . | P. aeruginosa . | E. coli . | Klebsiella spp. . | Enterobacter cloacae . | Prevotella spp. . | Proteus mirabilis . | Otherb . |
|---|---|---|---|---|---|---|---|---|
| Total No. of pathogens | 136 | 86 | 18 | 9 | 4 | 3 | 3 | 13 |
| Infection type | ||||||||
| Bone and joint | 40 (29) | 25 (29) | 5 (28) | 2 (22) | 1 (25) | 1 (33.3) | 1 (33.3) | 5 (39)b,c,d |
| Urinary tract | 32 (24) | 22 (26) | 4 (22) | 3 (33) | 1 (25) | … | … | 2 (15)e,f |
| Respiratory tract | 24 (18) | 20 (23) | … | 2 (22) | … | 1 (33.3) | … | 1 (8)g |
| Intra-abdominal | 21 (15) | 7 (8) | 7 (39) | 1 (11.5) | 1 (25) | 1 (33.3) | 1 (33.3) | 3 (23)d |
| Skin and soft tissue | 16 (12) | 10 (12) | 2 (11) | 1 (11.5) | … | … | 1 (33.3) | 2 (15)d |
| Bacteremia | 3 (2) | 2 (2) | … | … | 1 (25) | … | … | … |
| No. of resistant pathogens | 82 (60) | 61 (71) | 10 (56) | 5 (55) | 2 (50) | 2 (67) | 2 (15) | |
| MDR | 24 (18) | 22 (26) | … | 1 (11) | … | … | … | 1 (7.5)f |
| ESBL | 17 (12) | … | 9 (50) | 4 (44) | 2 (50) | 2 (67) | … | … |
| CR | 5 (3.7) | 4 (5) | … | … | … | … | … | 1 (7.5)e |
| MDR/ESBL | 1 (0.7) | … | 1 (6) | … | … | … | … | … |
| MDR/CR | 35 (26) | 35 (40) | … | … | … | … | … | … |
| Characteristic . | No. of Gram-Negative Pathogensa . | P. aeruginosa . | E. coli . | Klebsiella spp. . | Enterobacter cloacae . | Prevotella spp. . | Proteus mirabilis . | Otherb . |
|---|---|---|---|---|---|---|---|---|
| Total No. of pathogens | 136 | 86 | 18 | 9 | 4 | 3 | 3 | 13 |
| Infection type | ||||||||
| Bone and joint | 40 (29) | 25 (29) | 5 (28) | 2 (22) | 1 (25) | 1 (33.3) | 1 (33.3) | 5 (39)b,c,d |
| Urinary tract | 32 (24) | 22 (26) | 4 (22) | 3 (33) | 1 (25) | … | … | 2 (15)e,f |
| Respiratory tract | 24 (18) | 20 (23) | … | 2 (22) | … | 1 (33.3) | … | 1 (8)g |
| Intra-abdominal | 21 (15) | 7 (8) | 7 (39) | 1 (11.5) | 1 (25) | 1 (33.3) | 1 (33.3) | 3 (23)d |
| Skin and soft tissue | 16 (12) | 10 (12) | 2 (11) | 1 (11.5) | … | … | 1 (33.3) | 2 (15)d |
| Bacteremia | 3 (2) | 2 (2) | … | … | 1 (25) | … | … | … |
| No. of resistant pathogens | 82 (60) | 61 (71) | 10 (56) | 5 (55) | 2 (50) | 2 (67) | 2 (15) | |
| MDR | 24 (18) | 22 (26) | … | 1 (11) | … | … | … | 1 (7.5)f |
| ESBL | 17 (12) | … | 9 (50) | 4 (44) | 2 (50) | 2 (67) | … | … |
| CR | 5 (3.7) | 4 (5) | … | … | … | … | … | 1 (7.5)e |
| MDR/ESBL | 1 (0.7) | … | 1 (6) | … | … | … | … | … |
| MDR/CR | 35 (26) | 35 (40) | … | … | … | … | … | … |
Abbreviations: CLABSI, central line bloodstream infection; CR, carbapenem-resistant; ESBL, extended-spectrum beta-lactamase; MDR, multidrug-resistant; No., number.
Values represent number (%) of gram-negative isolates based on total no. of pathogens.
Bacteroides spp. (n = 2).
Providencia stuartii (n = 1).
Unspecified gram-negative rods.
Achromobacter nitrificans (n = 1).
Citrobacter koseri (n = 1).
Stenotrophomonas maltophilia (n = 1).
| Characteristic . | No. of Gram-Negative Pathogensa . | P. aeruginosa . | E. coli . | Klebsiella spp. . | Enterobacter cloacae . | Prevotella spp. . | Proteus mirabilis . | Otherb . |
|---|---|---|---|---|---|---|---|---|
| Total No. of pathogens | 136 | 86 | 18 | 9 | 4 | 3 | 3 | 13 |
| Infection type | ||||||||
| Bone and joint | 40 (29) | 25 (29) | 5 (28) | 2 (22) | 1 (25) | 1 (33.3) | 1 (33.3) | 5 (39)b,c,d |
| Urinary tract | 32 (24) | 22 (26) | 4 (22) | 3 (33) | 1 (25) | … | … | 2 (15)e,f |
| Respiratory tract | 24 (18) | 20 (23) | … | 2 (22) | … | 1 (33.3) | … | 1 (8)g |
| Intra-abdominal | 21 (15) | 7 (8) | 7 (39) | 1 (11.5) | 1 (25) | 1 (33.3) | 1 (33.3) | 3 (23)d |
| Skin and soft tissue | 16 (12) | 10 (12) | 2 (11) | 1 (11.5) | … | … | 1 (33.3) | 2 (15)d |
| Bacteremia | 3 (2) | 2 (2) | … | … | 1 (25) | … | … | … |
| No. of resistant pathogens | 82 (60) | 61 (71) | 10 (56) | 5 (55) | 2 (50) | 2 (67) | 2 (15) | |
| MDR | 24 (18) | 22 (26) | … | 1 (11) | … | … | … | 1 (7.5)f |
| ESBL | 17 (12) | … | 9 (50) | 4 (44) | 2 (50) | 2 (67) | … | … |
| CR | 5 (3.7) | 4 (5) | … | … | … | … | … | 1 (7.5)e |
| MDR/ESBL | 1 (0.7) | … | 1 (6) | … | … | … | … | … |
| MDR/CR | 35 (26) | 35 (40) | … | … | … | … | … | … |
| Characteristic . | No. of Gram-Negative Pathogensa . | P. aeruginosa . | E. coli . | Klebsiella spp. . | Enterobacter cloacae . | Prevotella spp. . | Proteus mirabilis . | Otherb . |
|---|---|---|---|---|---|---|---|---|
| Total No. of pathogens | 136 | 86 | 18 | 9 | 4 | 3 | 3 | 13 |
| Infection type | ||||||||
| Bone and joint | 40 (29) | 25 (29) | 5 (28) | 2 (22) | 1 (25) | 1 (33.3) | 1 (33.3) | 5 (39)b,c,d |
| Urinary tract | 32 (24) | 22 (26) | 4 (22) | 3 (33) | 1 (25) | … | … | 2 (15)e,f |
| Respiratory tract | 24 (18) | 20 (23) | … | 2 (22) | … | 1 (33.3) | … | 1 (8)g |
| Intra-abdominal | 21 (15) | 7 (8) | 7 (39) | 1 (11.5) | 1 (25) | 1 (33.3) | 1 (33.3) | 3 (23)d |
| Skin and soft tissue | 16 (12) | 10 (12) | 2 (11) | 1 (11.5) | … | … | 1 (33.3) | 2 (15)d |
| Bacteremia | 3 (2) | 2 (2) | … | … | 1 (25) | … | … | … |
| No. of resistant pathogens | 82 (60) | 61 (71) | 10 (56) | 5 (55) | 2 (50) | 2 (67) | 2 (15) | |
| MDR | 24 (18) | 22 (26) | … | 1 (11) | … | … | … | 1 (7.5)f |
| ESBL | 17 (12) | … | 9 (50) | 4 (44) | 2 (50) | 2 (67) | … | … |
| CR | 5 (3.7) | 4 (5) | … | … | … | … | … | 1 (7.5)e |
| MDR/ESBL | 1 (0.7) | … | 1 (6) | … | … | … | … | … |
| MDR/CR | 35 (26) | 35 (40) | … | … | … | … | … | … |
Abbreviations: CLABSI, central line bloodstream infection; CR, carbapenem-resistant; ESBL, extended-spectrum beta-lactamase; MDR, multidrug-resistant; No., number.
Values represent number (%) of gram-negative isolates based on total no. of pathogens.
Bacteroides spp. (n = 2).
Providencia stuartii (n = 1).
Unspecified gram-negative rods.
Achromobacter nitrificans (n = 1).
Citrobacter koseri (n = 1).
Stenotrophomonas maltophilia (n = 1).
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
